Pfizer Inc. PFE

28.67 0.26 0.92% as of 25 Sep
Market cap
$161.7B
P/E
37.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

10.59% 8.87% 8.28% 4.97%
ROA
4.59% 3.69% 3.60% 2.13%
ROIC
6.13% 6.45% 6.41% 6.30%
Return on Tangible Assets
33.65% 30.80% 26.87% 15.62%
Average Days of Receivables
82.90 69.26 72.55 71.57
Free Cash Flow per Share
1.83 1.60 1.67 1.93
Free Cash Flow
10,376.00 9,075.00 9,483.00 10,985.00
Capital Expenditures
(2,701.00) (2,629.00) (2,501.00) (2,416.00)
Piotroski F-Score
8.00 6.00 5.00 6.00
Other line items
Cash ROIC
7.70% 7.09% 7.14% 8.36%
Accounts Receivable Turnover
4.37 5.36 5.18 5.19
Accounts Payable Turnover
3.23 2.96 3.44 3.51
Inventory Turnover
1.44 1.49 1.56 1.58
Average Days of Payables
109.78 119.04 98.07 97.87
Days of Inventory on Hand
250.59 242.03 232.17 212.48
Tax Rate
0.07 0.04 (0.05) 0.04
Research and Development Expense of Revenue
16.35% 16.68% 16.94% 17.35%
Selling, General and Administrative Expense of Revenue
22.15% 22.04% 21.68% 21.54%
Share Based Compensation of Revenue
1.20% 1.28% 1.42% 1.49%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.33 1.51 1.60 3.09
Depreciation/Fixed assets
0.35 0.34 0.34 0.35
Capex/Depreciation
(0.40) (0.40) (0.38) (0.37)
Revenue per Share
11.04 11.01 11.13 11.18
Operating CF per Share
2.30 2.06 2.11 2.35
Capex per Share
(0.48) (0.46) (0.44) (0.42)
Capex to Sales
0.04 0.04 0.04 0.04
Net Profit Margin
15.65% 12.42% 11.83% 6.80%

Fold the line items

Columns are period end dates